School of Medicine

Michael J. Greenberg, at WashU Medicine, has received two grants from the National Institutes of Health (NIH) to investigate the complex roles of troponin — a critical protein in the heart — in various forms of heart failure.

Philip Payne, vice chancellor for biomedical informatics and data science at WashU Medicine and chief health AI officer for BJC Health and WashU Medicine, will lead the American Medical Informatics Association.

Research from WashU psychologists finds perception of neighborhood safety affects brain development.

As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.

Padma Gulur, MD, a physician-scientist and nationally recognized leader in pain management, has been named the head of the Department of Anesthesiology and the inaugural Alex S. Evers MD Distinguished Professor in Anesthesiology at WashU Medicine. Her appointment begins Aug. 1.

A study by researchers at WashU Medicine reveals how the body reprograms stable fat cells to eliminate stubborn fat reserves.

Researchers at WashU Medicine and Weizmann Institute of Science designed a CAR-T cell therapy that reduced amyloid beta plaques in the brains of mice, pointing to a promising new approach for Alzheimer’s disease.

The nine-story Gary C. Werths Building at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has earned Leadership in Energy and Environmental Design Gold certification from the U.S. Green Building Council.

A new tool developed by WashU Medicine researchers could allow for preemptive treatment of implant-related infections that improves outcomes and reduces patients’ emotional and financial burden.

A brain network first identified by WashU Medicine researchers, called SCAN, is shown in a new study to be the neurological basis for Parkinson’s disease. Patients receiving treatments targeted to this brain region, rather than to surrounding areas, experienced greater improvements in symptoms.